Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Fort Collins, Colorado, Oct. 01, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, "Antibody Production Market Size, Growth, Share, Statistics Analysis Report By Product...
-
TOFIDENCE (BIIB800) becomes the first tocilizumab biosimilar to gain FDA approval in the United StatesFDA approval is based on a robust analytical, non-clinical and clinical data package comparing...
-
New York, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The global oligonucleotide API market size is projected to expand at ~ 10% CAGR between 2023 and 2035. The market is expected to garner a revenue of USD...
-
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first and only FDA approved treatment for Friedreich’s ataxia in the U.S. CAMBRIDGE,...
-
LEQEMBI® Intravenous Infusion (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan
TOKYO and CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge,...
-
New York, Sept. 21, 2023 (GLOBE NEWSWIRE) -- The global IBD (Ulcerative Colitis and Crohn's Disease) treatment market is estimated to grow at a CAGR of ~8% over the forecast period. The market is...
-
Newark, Sept. 19, 2023 (GLOBE NEWSWIRE) -- The global Neuropathic Pain market is expected to grow from USD 5.10 billion in 2020 to USD 10 billion by 2028, at a CAGR of 7.73% during the forecast...
-
NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
-
NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
-
Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Antibodies Market, By Drug Type, by Disease Indication By End User, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...